What Health Canada’s New Special Access Program Amendments Mean For Medical Access To Psychedelics Dec 23, 2021
PharmaTher Enters Into Process Development Agreement With LTS LOHMANN for Ketamine Microneedle Patch Dec 20, 2021
MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second… Dec 16, 2021
Novamind Opens New Clinic Focused On Substance Use Disorders, Offering Alternative To Residential Treatment Dec 6, 2021
Braxia Scientific Wants To Offer Ketamine Treatments In ‘Less Restrictive’ Environments. Will It Be Safe? Dec 1, 2021
PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent… Nov 30, 2021